Literature DB >> 15827157

Viremia and nasal and rectal shedding of rotavirus in gnotobiotic pigs inoculated with Wa human rotavirus.

M S Azevedo1, L Yuan, K-I Jeong, A Gonzalez, T V Nguyen, S Pouly, M Gochnauer, W Zhang, A Azevedo, L J Saif.   

Abstract

Respiratory symptoms with rotavirus shedding in nasopharyngeal secretions have been reported in children with and without gastrointestinal symptoms (Zheng et al., 1991, J. Med. Virol. 34:29-37). To investigate if attenuated and virulent human rotavirus (HRV) strains cause upper respiratory tract infections or viremia in gnotobiotic pigs, we inoculated them with attenuated or virulent HRV intranasally, intravenously, or orally or via feeding tube (gavage) and assayed virus shedding. After oral or intranasal inoculation with attenuated HRV, the pigs remained asymptomatic, but 79 to 95% shed virus nasally and 5 to 17% shed virus rectally. After inoculation by gavage, no pigs shed virus nasally or rectally, but all pigs seroconverted with antibodies to HRV. No viremia was detected through postinoculation day 10. Controls inoculated intranasally with nonreplicating rotavirus-like particles or mock inoculated did not shed virus. In contrast, 100% of pigs inoculated with virulent HRV (oral, intranasal, or gavage) developed diarrhea, shed virus nasally and rectally, and had viremia. The infectivity of sera from the viremic virulent HRV-inoculated pigs was confirmed by inoculating gnotobiotic pigs orally with pooled HRV-positive serum. Serum-inoculated pigs developed diarrhea and fecal and nasal virus shedding and seroconverted with serum and intestinal HRV antibodies. Pigs inoculated intravenously with serum or intestinal contents from the viremic virulent HRV-inoculated pigs developed diarrhea, virus shedding, and viremia, similar to the orally inoculated pigs. This study provides new evidence that virulent HRV causes transient viremia and upper respiratory tract infection in addition to gastrointestinal infection in gnotobiotic pigs, confirming previous reports of rotavirus antigenemia (Blutt et al., Lancet 362:1445-1449, 2003). Our data also suggest that intestinal infection might be initiated from the basolateral side of the epithelial cells via viremia. Additionally, virus shedding patterns indicate a different pathogenesis for attenuated versus virulent HRV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827157      PMCID: PMC1082764          DOI: 10.1128/JVI.79.9.5428-5436.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Developmental immunity in the piglet.

Authors:  Y B Kim
Journal:  Birth Defects Orig Artic Ser       Date:  1975

2.  Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine during a phase 3 clinical trial in Caracas, Venezuela.

Authors:  Yasutaka Hoshino; Mariam Wagner; Xiao-Yi Yan; Irene Perez-Schael; Albert Z Kapikian
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

3.  Infection of cultured human intestinal cells by monkey RRV and human Wa rotavirus as a function of intestinal epithelial cell differentiation.

Authors:  N Jourdan; J Cotte Laffitte; F Forestier; A L Servin; A M Quéro
Journal:  Res Virol       Date:  1995 Sep-Oct

Review 4.  Transmission of rotavirus and other enteric pathogens in the home.

Authors:  P H Dennehy
Journal:  Pediatr Infect Dis J       Date:  2000-10       Impact factor: 2.129

5.  Comparative pathogenesis of tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC.

Authors:  M Guo; J Hayes; K O Cho; A V Parwani; L M Lucas; L J Saif
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Rotavirus genome segment 7 (NSP3) is a determinant of extraintestinal spread in the neonatal mouse.

Authors:  Eric C Mossel; Robert F Ramig
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection.

Authors:  Marli S P Azevedo; Lijuan Yuan; Cristiana Iosef; Kyeong-Ok Chang; Yunjeong Kim; Trang Van Nguyen; Linda J Saif
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

8.  Rotavirus antigenaemia and viraemia: a common event?

Authors:  Sarah E Blutt; Carl D Kirkwood; Viviana Parreño; Kelly L Warfield; Max Ciarlet; Mary K Estes; Karin Bok; Ruth F Bishop; Margaret E Conner
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

9.  The pathology of rotavirus-associated deaths, using new molecular diagnostics.

Authors:  Maureen Lynch; Wun-Ju Shieh; Kathleen Tatti; Jon R Gentsch; Tara Ferebee-Harris; Baoming Jiang; Jeannette Guarner; Joesph S Bresee; Margaret Greenwald; Steve Cullen; H D Davies; Cynthia Trevenen; Sherif R Zaki; Roger I Glass
Journal:  Clin Infect Dis       Date:  2003-10-23       Impact factor: 9.079

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more
  41 in total

1.  Expression of rotavirus NSP4 alters the actin network organization through the actin remodeling protein cofilin.

Authors:  Zuzana Berkova; Sue E Crawford; Sarah E Blutt; Andrew P Morris; Mary K Estes
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

2.  Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.

Authors:  Ke Wen; Marli S P Azevedo; Ana Gonzalez; Wei Zhang; Linda J Saif; Guohua Li; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

3.  Immune mediators of rotavirus antigenemia clearance in mice.

Authors:  Glendie Marcelin; Amber D Miller; Sarah E Blutt; Margaret E Conner
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Development of γδ T cell subset responses in gnotobiotic pigs infected with human rotaviruses and colonized with probiotic lactobacilli.

Authors:  Ke Wen; Guohua Li; Wei Zhang; Marli S P Azevedo; Linda J Saif; Fangning Liu; Tammy Bui; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2011-03-23       Impact factor: 2.046

5.  Rotavirus viremia and extraintestinal viral infection in the neonatal rat model.

Authors:  Sue E Crawford; Dinesh G Patel; Elly Cheng; Zuzana Berkova; Joseph M Hyser; Max Ciarlet; Milton J Finegold; Margaret E Conner; Mary K Estes
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs.

Authors:  Sonia Cheetham; Menira Souza; Tea Meulia; Sheila Grimes; Myung Guk Han; Linda J Saif
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

7.  Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Abdul Rauf; Stephanie N Langel; David E Wentworth; Karla M Stucker; Rebecca A Halpin; Ham Ching Lam; Douglas Marthaler; Linda J Saif; Anastasia N Vlasova
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

8.  Lactobacillus rhamnosus GG on rotavirus-induced injury of ileal epithelium in gnotobiotic pigs.

Authors:  Fangning Liu; Guohua Li; Ke Wen; Shaoping Wu; Yongguo Zhang; Tammy Bui; Xingdong Yang; Jacob Kocher; Jun Sun; Bernard Jortner; Lijuan Yuan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-12       Impact factor: 2.839

9.  Virus-specific intestinal IFN-gamma producing T cell responses induced by human rotavirus infection and vaccines are correlated with protection against rotavirus diarrhea in gnotobiotic pigs.

Authors:  Lijuan Yuan; Ke Wen; Marli S P Azevedo; Ana M Gonzalez; Wei Zhang; Linda J Saif
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

10.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.